Cargando…
Medications for early treatment of COVID‐19 in Australia
Early treatment of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infections can prevent hospitalisation and death in patients with coronavirus disease 2019 (COVID‐19) who have one or more risk factors for serious COVID‐19 progression. While early treatment presents a range of logistic...
Autores principales: | Polkinghorne, Adam, Branley, James M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828711/ https://www.ncbi.nlm.nih.gov/pubmed/36273391 http://dx.doi.org/10.5694/mja2.51750 |
Ejemplares similares
-
How COVID-19 Is Testing and Evolving Our Communication Skills
por: Julka-Anderson, Naman
Publicado: (2020) -
A review of the impact of the COVID-19 pandemic on pre-registration medical radiation science education
por: Ng, C.K.C.
Publicado: (2022) -
Treatment of COVID-19 with convalescent plasma: lessons from past coronavirus outbreaks
por: Wooding, Denise J., et al.
Publicado: (2020) -
Nudging healthcare professionals to improve treatment of COVID-19: a narrative review
por: Vilhelmsson, Andreas, et al.
Publicado: (2021) -
How to deliver aerosolized medications through high flow nasal cannula safely and effectively in the era of COVID-19 and beyond: A narrative review
por: Ari, Arzu, et al.
Publicado: (2021)